SURVEY ON THE CHARACTERISTICS AND CARBAPENEM RESISTANCE PHENOTYPES OF PSEUDOMONAS AERUGINOSA AT THONG NHAT HOSPITAL

Văn Hiệp Nguyễn, Minh Sơn Nguyễn, Kiến Thành Lâm, Ngọc Lân Nguyễn, Văn Chinh Nguyễn, Văn Chương Lê

Main Article Content

Abstract

Objectives: To investigate the characteristics and resistance phenotypes of Pseudomonas aeruginosa isolated from patients examined and treated at Thong Nhat Hospital during 2024–2025. Materials and Methods: A cross-sectional study was conducted on P. aeruginosa strains isolated from all types of clinical specimens collected from patients at Thong Nhat Hospital between 2024 and 2025. Results: Among the 230 Pseudomonas aeruginosa isolates collected during the study period, most were from patients aged ≥ 60 years, primarily hospitalized in Internal Medicine wards. The most common specimen type was respiratory samples (51.3%). The rate of carbapenem resistance was 47.8% (110/230 isolates). Among the 110 carbapenem-resistant isolates, 74.5% (82/110) were carbapenemase-producing P. aeruginosa (CP-PA, mCIM positive), while 25.5% (28/110) were non–CP-PA. Conclusion: The study demonstrated that most carbapenem-resistant P. aeruginosa isolates obtained at Thong Nhat Hospital during 2024–2025 were carbapenemase producers, strongly associated with multidrug and extensively drug-resistant phenotypes. These findings highlight the necessity of stringent infection control measures and prudent antibiotic stewardship to prevent the spread of resistant strains within the hospital setting

Article Details

References

1. World Health Organization. WHO bacterial priority pathogens list, 2024: bacterial pathogens of public health importance, to guide research, development, and strategies to prevent and control antimicrobial resistance: World Health Organization; 2024.
2. Nguyễn Thị Đoan Trinh, Phan Thị Lan Phương, Hoàng Thị Minh Hòa, Nguyễn Huy Hoàng. Đặc điểm gây bệnh và tính kháng kháng sinh của Pseudomonas aeruginosa tại Bệnh viện C Đà Nẵng. Tạp chí Y Dược học Cần Thơ. 2023(58):159-66.
3. Qin J, Zou C, Tao J, Wei T, Yan L, Zhang Y, et al. Carbapenem resistant Pseudomonas aeruginosa infections in elderly patients: antimicrobial resistance profiles, risk factors and impact on clinical outcomes. Infection and Drug Resistance. 2022:2301-14.
4. Horcajada JP, Montero M, Oliver A, Sorlí L, Luque S, Gómez-Zorrilla S, et al. Epidemiology and treatment of multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa infections. Clinical microbiology reviews. 2019;32(4):10.1128/cmr. 00031-19.
5. Ramatla T, Nkhebenyane J, Lekota KE, Thekisoe O, Monyama M, Achilonu CC, et al. Global prevalence and antibiotic resistance profiles of carbapenem-resistant Pseudomonas aeruginosa reported from 2014 to 2024: a systematic review and meta-analysis. Front Microbiol. 2025;16:1599070. Epub 2025/08/05. doi: 10.3389/fmicb.2025.1599070. PubMed PMID: 40761277; PubMed Central PMCID: PMCPMC12318982.
6. Dương Quang Hiệp, Lê Văn Cường. Sự phân bố và tính kháng thuốc của trực khuẩn mủ xanh tại Bệnh viện Đa khoa tỉnh Thanh Hóa năm 2020= Distribution and antibiotic resistance in P. aeruginosa at Thanh Hoa province general hospital. 2022.
7. Soltani B, Ahmadrajabi R, Kalantar-Neyestanaki D. Critical resistance to carbapenem and aminoglycosides in Pseudomonas aeruginosa: Spread of bla NDM/16S methylase armA harboring isolates with intrinsic resistance mechanisms in Kerman, Iran. BMC Infectious Diseases. 2024;24(1):1188.
8. Trần Hải Anh, Vu TNB, Trinh ST, Tran DL, Pham HM, Ngo THH, et al. Resistance mechanisms and genetic relatedness among carbapenem-resistant Pseudomonas aeruginosa isolates from three major hospitals in Hanoi, Vietnam (2011-15). JAC Antimicrob Resist. 2021;3(3):dlab103. Epub 2021/07/30. doi: 10.1093/jacamr/dlab103. PubMed PMID: 34322671; PubMed Central PMCID: PMCPMC8313516.